Cargando…

Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy

Bevacizumab is thought to normalize tumor vasculature and restore the blood–brain barrier, decreasing enhancement and peritumoral edema. Conventional measurements of tumor response rely upon dimensions of enhancing tumor. After bevacizumab treatment, glioblastomas are more prone to progress as nonen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pope, Whitney B., Young, Jonathan R., Ellingson, Benjamin M.
Formato:	Texto
Lenguaje:	English
Publicado:	Current Science Inc. 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075404/ https://www.ncbi.nlm.nih.gov/pubmed/21234719 http://dx.doi.org/10.1007/s11910-011-0179-x

Ejemplares similares

Characterization of cognitive function in survivors of diffuse gliomas using resting-state functional MRI (rs-fMRI)
por: Wang, Chencai, et al.
Publicado: (2021)

BIMG-11. PHARMACODYNAMIC EVALUATION OF IDH AND EGFR INHIBITION IN HUMAN GLIOMAS USING MOLECULAR MRI
por: Ellingson, Benjamin, et al.
Publicado: (2021)

Modeling the efficacy of the extent of surgical resection in the setting of radiation therapy for glioblastoma
por: Hathout, Leith, et al.
Publicado: (2016)

Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma
por: Patel, Kunal S., et al.
Publicado: (2020)

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI
por: Hagiwara, Akifumi, et al.
Publicado: (2022)

Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study
por: Yao, Jingwen, et al.
Publicado: (2020)

SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI()()
por: Deng, Lei, et al.
Publicado: (2016)

Anti-VEGF Therapy and the Retina: An Update
por: Tah, Vikas, et al.
Publicado: (2015)

Association between lesion location and language function in adult glioma using voxel-based lesion-symptom mapping
por: Banerjee, Pia, et al.
Publicado: (2015)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010)

Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation Networks
por: Wang, Chencai, et al.
Publicado: (2022)

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
por: Tatekawa, Hiroyuki, et al.
Publicado: (2021)

The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China
por: Shen, Guiquan, et al.
Publicado: (2020)

Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration
por: Balikova, Irina, et al.
Publicado: (2019)

The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization
por: Chen, Qin, et al.
Publicado: (2016)

Tumor refractoriness to anti-VEGF therapy
por: Ribatti, Domenico
Publicado: (2016)

Diffusion MRI Characteristics After Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma
por: Chang, Warren, et al.
Publicado: (2015)

(18)F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma
por: Nedergaard, Mette Kjoelhede, et al.
Publicado: (2015)

Predictive Assessment of Quantitative Ultra-Widefield Angiographic Features for Future Need for Anti-VEGF Therapy in Diabetic Eye Disease
por: Jiang, Alice C., et al.
Publicado: (2022)

Advances in co-opting anti-depressant drugs in glioma therapy
por: Pant, Ayush, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study
por: Yao, Jingwen, et al.
Publicado: (2022)

Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
por: Schneider, Bryan P, et al.
Publicado: (2009)

Anti-VEGF Cancer Therapy in Nephrology Practice
por: Izzedine, Hassan
Publicado: (2014)

The remote effects of intravitreal anti-VEGF therapy
por: Balta, F, et al.
Publicado: (2016)

Leukostasis retinopathy treated with Anti-VEGF therapy
por: Shakibai, Nasim, et al.
Publicado: (2020)

The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
por: Galldiks, Norbert, et al.
Publicado: (2016)

Evaluation of microaneurysms as predictors of therapeutic response to anti-VEGF therapy in patients with DME
por: Hatano, Makoto, et al.
Publicado: (2022)

The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
por: Lieu, Christopher H., et al.
Publicado: (2013)

Biomarkers as Predictive Factors of Anti-VEGF Response
por: Bobadilla, Miriam, et al.
Publicado: (2022)

Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas
por: Cho, Nicholas S., et al.
Publicado: (2023)

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
por: Wang, Tianqin, et al.
Publicado: (2021)

Mechanisms of adverse effects of anti-VEGF therapy for cancer
por: Kamba, T, et al.
Publicado: (2007)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
por: Yerramothu, Praveen
Publicado: (2018)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
por: Martini, Maurizio, et al.
Publicado: (2018)

A serum metabolomics study of patients with nAMD in response to anti-VEGF therapy
por: Gao, Yan, et al.
Publicado: (2020)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
por: Faatz, Henrik, et al.
Publicado: (2022)

Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI
por: Hu, Yue, et al.
Publicado: (2020)

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance
por: Ma, Shaolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_di7rnoeadilr1409hgj13qpj3p